ARCHIVES

ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies

This article is from The Cancer Letter archive.

Vol. 38 No. 25 | June 22, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Gets $867 Million From Conferees; Grants To Be Funded At 41-42% Including Some Holdovers

July 29, 1977

Study tests a “truth” in radiation oncology, raises questions about anemia treatment.

October 24, 2003

Eppley Contract Renewed; To Be Recompeted

January 20, 1978

Raub Corrects Record on ALERT

April 20, 1984

Nutrition, Disease Oriented Contracts

December 4, 1981

Senate Finance Reports A Reform Bill On Deadline

July 8, 1994